• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

易患中耳炎儿童对不可分型流感嗜血杆菌外膜蛋白的抗体反应。

Antibody response to outer membrane protein of nontypeable Haemophilus influenzae in otitis-prone children.

作者信息

Yamanaka N, Faden H

机构信息

Department of Otolaryngology, Sapporo Medical College, Japan.

出版信息

J Pediatr. 1993 Feb;122(2):212-8. doi: 10.1016/s0022-3476(06)80115-0.

DOI:10.1016/s0022-3476(06)80115-0
PMID:8429433
Abstract

One of the major outer membrane proteins of nontypeable Haemophilus influenzae, P6, is highly conserved among strains, serves as a target for bactericidal antibody, and has been proposed as a possible vaccine candidate. The serum antibody response to P6 was studied in otitis-prone and normal children by an enzyme-linked immunosorbent assay. Of 20 otitis-prone children, 12 (60%) had a serum IgG antibody response to P6 after otitis media; however, the mean acute antibody level for the group, 4.6 micrograms/ml, was not significantly different from the convalescent level, 5.4 micrograms/ml. Anti-P6 antibody levels were also measured longitudinally for 10 to 25 months in 30 otitis-prone and 13 healthy children. Antibody levels increased sevenfold in the normal group compared with less than three-fold for the otitis-prone group and were significantly higher in the normal children after the age of 18 months (p < 0.05). Finally, otitis-prone children who had two or more episodes of otitis media with nontypeable H. influenzae did not have an anamnestic antibody response to P6. The failure to recognize P6 as a specific immunogen may account for recurrent infections. Moreover, the data suggest that otitis-prone children may not respond adequately to a vaccine containing P6.

摘要

不可分型流感嗜血杆菌的主要外膜蛋白之一P6,在菌株间高度保守,是杀菌性抗体的靶点,并已被提议作为一种可能的疫苗候选物。通过酶联免疫吸附测定法研究了易患中耳炎儿童和正常儿童对P6的血清抗体反应。在20名易患中耳炎的儿童中,12名(60%)在患中耳炎后对P6有血清IgG抗体反应;然而,该组的平均急性期抗体水平为4.6微克/毫升,与恢复期水平5.4微克/毫升无显著差异。还对30名易患中耳炎儿童和13名健康儿童进行了10至25个月的纵向抗P6抗体水平测量。正常组抗体水平增加了7倍,而易患中耳炎组不到3倍,且18个月后正常儿童的抗体水平显著更高(p<0.05)。最后,患有两次或更多次由不可分型流感嗜血杆菌引起的中耳炎的易患中耳炎儿童对P6没有回忆性抗体反应。未能将P6识别为特异性免疫原可能是反复感染的原因。此外,数据表明易患中耳炎儿童可能对含P6的疫苗反应不佳。

相似文献

1
Antibody response to outer membrane protein of nontypeable Haemophilus influenzae in otitis-prone children.易患中耳炎儿童对不可分型流感嗜血杆菌外膜蛋白的抗体反应。
J Pediatr. 1993 Feb;122(2):212-8. doi: 10.1016/s0022-3476(06)80115-0.
2
Bactericidal antibody response against P6, protein D, and OMP26 of nontypeable Haemophilus influenzae after acute otitis media in otitis-prone children.易患中耳炎儿童急性中耳炎后针对不可分型流感嗜血杆菌P6、蛋白D和OMP26的杀菌抗体反应。
FEMS Immunol Med Microbiol. 2012 Aug;65(3):439-47. doi: 10.1111/j.1574-695X.2012.00967.x. Epub 2012 May 9.
3
Serum antibody response to three non-typeable Haemophilus influenzae outer membrane proteins during acute otitis media and nasopharyngeal colonization in otitis prone and non-otitis prone children.血清抗体对三种不可分型流感嗜血杆菌外膜蛋白的反应在易患和不易患中耳炎的儿童急性中耳炎和鼻咽定植期间。
Vaccine. 2011 Jan 29;29(5):1023-8. doi: 10.1016/j.vaccine.2010.11.055. Epub 2010 Dec 1.
4
Antibody response to Haemophilus influenzae outer membrane protein D, P6, and OMP26 after nasopharyngeal colonization and acute otitis media in children.儿童鼻咽部定植和急性中耳炎后对流感嗜血杆菌外膜蛋白 D、P6 和 OMP26 的抗体反应。
Vaccine. 2010 Oct 18;28(44):7184-92. doi: 10.1016/j.vaccine.2010.08.063. Epub 2010 Aug 26.
5
Immunoglobulin G subclass response to major outer membrane proteins of nontypable Haemophilus influenzae in children with acute otitis media.急性中耳炎患儿对不可分型流感嗜血杆菌主要外膜蛋白的免疫球蛋白G亚类反应
Otolaryngol Head Neck Surg. 1997 Mar;116(3):363-71. doi: 10.1016/S0194-59989770275-4.
6
Local antibody response to P6 of nontypable Haemophilus influenzae in otitis-prone and normal children.易患中耳炎儿童和正常儿童对不可分型流感嗜血杆菌P6的局部抗体反应。
Acta Otolaryngol. 1993 Jul;113(4):524-9. doi: 10.3109/00016489309135857.
7
Serum antibodies specific to CD outer membrane protein of Moraxella catarrhalis, P6 outer membrane protein of non-typeable Haemophilus influenzae and capsular polysaccharides of Streptococcus pneumoniae in children with otitis media with effusion.分泌性中耳炎患儿中针对卡他莫拉菌CD外膜蛋白、不可分型流感嗜血杆菌P6外膜蛋白及肺炎链球菌荚膜多糖的血清特异性抗体。
Acta Otolaryngol. 1998 Nov;118(6):826-32. doi: 10.1080/00016489850182521.
8
Serum Concentrations of Antibodies against Outer Membrane Protein P6, Protein D, and T- and B-Cell Combined Antigenic Epitopes of Nontypeable Haemophilus influenzae in Children and Adults of Different Ages.不同年龄段儿童和成人中抗不可分型流感嗜血杆菌外膜蛋白P6、蛋白D以及T细胞和B细胞联合抗原表位抗体的血清浓度
Clin Vaccine Immunol. 2015 Dec 16;23(2):155-61. doi: 10.1128/CVI.00506-15. Print 2016 Feb.
9
Breast-feeding is associated with a reduced frequency of acute otitis media and high serum antibody levels against NTHi and outer membrane protein vaccine antigen candidate P6.母乳喂养与急性中耳炎的发生频率降低以及针对 NTHi 和外膜蛋白疫苗候选抗原 P6 的高血清抗体水平相关。
Pediatr Res. 2009 Nov;66(5):565-70. doi: 10.1203/PDR.0b013e3181b4f8a6.
10
Human milk secretory IgA antibody to nontypeable Haemophilus influenzae: possible protective effects against nasopharyngeal colonization.人乳中针对不可分型流感嗜血杆菌的分泌型 IgA 抗体:对鼻咽部定植可能的保护作用。
J Pediatr. 1994 Feb;124(2):193-8. doi: 10.1016/s0022-3476(94)70302-7.

引用本文的文献

1
Induction of Mucosal IgA-Mediated Protective Immunity Against Nontypeable Infection by a Cationic Nanogel-Based P6 Nasal Vaccine.阳离子纳米凝胶 P6 鼻用疫苗诱导黏膜 IgA 介导的非分型 感染保护性免疫。
Front Immunol. 2022 Jul 6;13:819859. doi: 10.3389/fimmu.2022.819859. eCollection 2022.
2
The Peptidoglycan-associated lipoprotein Pal contributes to the virulence of and provides protection against lethal aerosol challenge.肽聚糖相关脂蛋白 Pal 有助于 的毒力,并提供针对致死性气溶胶挑战的保护。
Virulence. 2020 Dec;11(1):1024-1040. doi: 10.1080/21505594.2020.1804275.
3
Australian Aboriginal Children with Otitis Media Have Reduced Antibody Titers to Specific Nontypeable Haemophilus influenzae Vaccine Antigens.
患有中耳炎的澳大利亚原住民儿童针对特定不可分型流感嗜血杆菌疫苗抗原的抗体滴度降低。
Clin Vaccine Immunol. 2017 Apr 5;24(4). doi: 10.1128/CVI.00556-16. Print 2017 Apr.
4
Serum Concentrations of Antibodies against Outer Membrane Protein P6, Protein D, and T- and B-Cell Combined Antigenic Epitopes of Nontypeable Haemophilus influenzae in Children and Adults of Different Ages.不同年龄段儿童和成人中抗不可分型流感嗜血杆菌外膜蛋白P6、蛋白D以及T细胞和B细胞联合抗原表位抗体的血清浓度
Clin Vaccine Immunol. 2015 Dec 16;23(2):155-61. doi: 10.1128/CVI.00506-15. Print 2016 Feb.
5
IgG responses to Pneumococcal and Haemophilus influenzae protein antigens are not impaired in children with a history of recurrent acute otitis media.曾反复发作急性中耳炎的儿童对肺炎球菌和流感嗜血杆菌蛋白抗原的 IgG 应答未受损。
PLoS One. 2012;7(11):e49061. doi: 10.1371/journal.pone.0049061. Epub 2012 Nov 12.
6
Maternal immunization with pneumococcal surface protein A protects against pneumococcal infections among derived offspring.母体接种肺炎球菌表面蛋白 A 可预防衍生后代的肺炎球菌感染。
PLoS One. 2011;6(10):e27102. doi: 10.1371/journal.pone.0027102. Epub 2011 Oct 31.
7
Serum antibody response to five Streptococcus pneumoniae proteins during acute otitis media in otitis-prone and non-otitis-prone children.在易患和不易患中耳炎的儿童急性中耳炎期间,对五种肺炎链球菌蛋白的血清抗体反应。
Pediatr Infect Dis J. 2011 Aug;30(8):645-50. doi: 10.1097/INF.0b013e31821c2d8b.
8
Serum antibody response to three non-typeable Haemophilus influenzae outer membrane proteins during acute otitis media and nasopharyngeal colonization in otitis prone and non-otitis prone children.血清抗体对三种不可分型流感嗜血杆菌外膜蛋白的反应在易患和不易患中耳炎的儿童急性中耳炎和鼻咽定植期间。
Vaccine. 2011 Jan 29;29(5):1023-8. doi: 10.1016/j.vaccine.2010.11.055. Epub 2010 Dec 1.
9
Antibody response to Haemophilus influenzae outer membrane protein D, P6, and OMP26 after nasopharyngeal colonization and acute otitis media in children.儿童鼻咽部定植和急性中耳炎后对流感嗜血杆菌外膜蛋白 D、P6 和 OMP26 的抗体反应。
Vaccine. 2010 Oct 18;28(44):7184-92. doi: 10.1016/j.vaccine.2010.08.063. Epub 2010 Aug 26.
10
Epitope mapping immunodominant regions of the PilA protein of nontypeable Haemophilus influenzae (NTHI) to facilitate the design of two novel chimeric vaccine candidates.鉴定非典型流感嗜血杆菌(NTHI)PilA 蛋白的免疫显性区域,以促进两种新型嵌合疫苗候选物的设计。
Vaccine. 2009 Dec 10;28(1):279-89. doi: 10.1016/j.vaccine.2009.08.017. Epub 2009 Aug 22.